Galimi Francesco has filed 4 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 375077 shares of Adicet Bio, Inc. ($ACET) on June 05, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2024 | Adicet Bio, Inc. | $ACET | Galimi Francesco | SVP & Chief Medical Officer | A | Stock Option (Right to Buy) | 375077 | $0.00 | 375,077.0000 | 0 | 9999.99% | 0.00% |
| Jan. 24, 2024 | Adicet Bio, Inc. | $ACET | Galimi Francesco | SVP & Chief Medical Officer | F | Common Stock | 4957 | $2.40 | 75,501.0000 | 0 | 6.16% | 0.00% |
| Jan. 24, 2024 | Adicet Bio, Inc. | $ACET | Galimi Francesco | SVP & Chief Medical Officer | A | Common Stock | 26300 | $0.00 | 101,801.0000 | 0 | 34.83% | 0.00% |
| Jan. 24, 2024 | Adicet Bio, Inc. | $ACET | Galimi Francesco | SVP & Chief Medical Officer | A | Stock Option (Right to Buy) | 288134 | $0.00 | 288,134.0000 | 0 | 9999.99% | 0.00% |